bpc-157 mechanisms of action review Peptide Therapy for Inflammation: A New Solution Multifunctionality and Possible Medical Application

Each dose draws 0.10 mL, so: 3.00 mL 0.10 mL = 30 doses per vial How long 30 doses lasts depends entirely on frequency which is the whole point of the phase schedule: Practically, roughly one vial per month covers the daily loading phase, and the same vial stretches much further once you drop to maintenance frequency

The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis

Warnings Patients with early Leber's disease (hereditary optic nerve atrophy) who were treated with cyanocobalamin suffered severe and swift optic atrophy

Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review

PMID 36249776